Lower Respiratory Tract Infections Flashcards

1
Q

What organism etiologies are in CAP?

A
Strep pneumo
H. Influenzae
Staph aureus
Mycoplasma pneumoniae
PSA
Legionella
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do you define severe CAP?

A
Major Criteria (at least 1 major)
Septic shock with need for vasopressors
Resp failure needing mechanical ventilation
Minor criteria (at least 3 minor)
RR > 30
FaO2/FiO2 < 250
Multilobar infiltrates
Confusion/disorientation
BUN > 20
WBC > 4000
Plt < 100000
Hypothermia < 36C
Hypotension requiring aggressive fluid resuscitation

1 major or 3 minor consider ICU admission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What classifications are there for Pneumonia severity index or Pneumonia Outcomes Research Team and how to they determine outpatient or inpatient management?

A
Risk class I or II - outpatient
Risk class III - observation
Risk class IV or V - inpatient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is CURB-65?

A
Confusion
BUN > 20
RR > 30
BP < 90/60
Age > 65
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is first line empiric adult outpatient CAP?

A

HD Amoxicillin 1 g TID is preferred
Doxycycline
Macrolide - only if amox or doxy are CI and macrolide resistant S. Pneumoniae known to be infrequent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What comorbidies are considered for poor CAP outcomes or resistant strep pneumo?

A
Heart disease 
Lung disease
Liver disease
Renal disease
Diabetes
Alcoholism
Malignancy
Asplenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What empiric therapy should be considered in a patient with comorbidies to CAP?

A
B lactam (augmentin, cefpodoxime, cefuroxime) + macrolide OR doxycycline
Levofloxacin or moxifloxacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When should anaerobic coverage be used for aspiration pneumonia?

A

Empyema

Lung abscess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What other treatment considerations should be made for CAP?

A

Give neuromidase inhibitor regardless of time

Give steroids only in shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What directed therapy is preferred in common CAP organisms?

A

S. Pneumo PCN S - Amoxicillin
S. Pneumo PCN R - Cefotaxime, CTX, FQs

H. Influenzae non B lactamase producing - Amoxicillin
B lactamase producing - 2nd or 3rd generation cephalosporins

Legionella - FQs, macrolides
MRSA - vancomycin, linezolid
MSSA - anti-Staph PCN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What antibacterial coverage is for omadacycline?

A

MRSA and drug resistant S. Pneumo

H. Influenzae
M. Catarrhalis

No coverage in Proteus, PSA, morganella or providencia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the preferred duration of therapy for CAP?

A

Minimum 5 days
7 days if suspected or proven MRSA or PSA
Serial PCT can be used to support d/c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When should a patient receive influenza treatment?

A

Outpatient, uncomplicated, no risk factors - Tamiflu or Zanamivir x 5 days

  • < 2 days since onset
  • household contact with patients high risk of complications such as immunocompromised

Outpatient, risk factor for complications
Tamiflu or inhaled Zanamivir for 5 days
Consider longer duration if complicated/immunocompromised
- Tamiflu preferred in pregnancy and COPD/asthma

Inpatient
Tamiflu or IV prramivir if unable to absorb PO for 5 days

*Risk factors
Age < 2 or age > 65
Chronic pulmonary
Cardiovascular
Renal or hepatic disease
DM
Immunosuppression
Pregnancy or <2 weeks postpartum
Nursing home
Obesity BMI > 40
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What CAP organisms are expected for pediatric patients?

A

Strep pneumo
Mycoplasma pneumoniae
Staph aureus
Strep viridans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do you treat pediatric CAP?

A

< 5 years Amoxicillin, alternative: augmentin
> 5 years Amoxicillin, alternative: augmentin and add macrolide if no data to differentiate typical from atypical

Atypical bacteria: azithromycin or clarithromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the common pathogens for HAP and VAP?

A
  • PSA
  • Acinetobacter spp.
  • Enteric GNR
  • MSSA
  • MRSA
17
Q

When should double PSA coverage be used in HAP?

A
  • High mortality risk
  • IV abs in prior 90 days
  • Structural lung disease (bronchiectasis or CF)
18
Q

What are risk factors for MDR VAP?

A
  • IV antibiotics in past 90 days
  • Septic shock
  • ARDs preceding VAP
  • > 5 days of hospitalization prior to VAP
  • Acute renal replacement therapy prior to VAP
  • GNR resistance > 10%
19
Q

For HAP/VAP, when should PSA directed therapy be de-escalated to monotherapy?

A

Septic shock or high mortality risk resolution

20
Q

What is the AUC/MIC goal for vancomycin for complicated S. aureus infections?

A

400 mgxhr/L with MIC of 1 mg/L

21
Q

How to calculate dosing interval change in individualized vancomycin dosing?

A

tau(new) x Css (new) = tau (old) X Css (old)

22
Q

How to calculate both change in dose and interval for vancomycin?

A

Css new divided 24 hr dose new = Css (old) divided 24 hr dose old

23
Q

What are the advantages of polymyxin B over colistin?

A

Polymyxin has less acute kidney injury and PK optimization is more likely (Css of 2 mg/L or AUC = 50)

24
Q

What to HAP/VAP guidelines say about using polymyxin?

A

Avoid when possible since exposure required for success in lower respiratory tract infection is above max tolerable range. Always use polymyxin with systemic agent even if resistant and use inhaled polymyxin for XDR GNR

25
Q

What diagnostic considerations should be considered to discontinue HAP/VAP?

A
  • Clinical criteria

- Procalcitonin